Torley Helen
CIK 1528185
Transactions on file
125
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-08-20 | 2026-08-19 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 3,200 | $344.8K | +0.5% | open → |
| 2026-08-20 | 2026-08-19 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 9,600 | $1.03M | +1.0% | open → |
| 2026-08-20 | 2026-08-19 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 7,200 | $765.8K | +1.8% | open → |
| 2026-08-20 | 2026-08-19 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $368.2K | +488.3% | open → |
| 2026-08-20 | 2026-08-18 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 9,400 | $985.8K | +3.3% | open → |
| 2026-08-20 | 2026-08-18 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 4,897 | $509.8K | +4.0% | open → |
| 2026-08-20 | 2026-08-18 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 5,703 | $587.9K | +5.1% | open → |
| 2026-08-20 | 2026-08-18 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $368.2K | +488.3% | open → |
| 2026-08-20 | 2026-08-17 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 7,500 | $776.1K | +4.7% | open → |
| 2026-08-20 | 2026-08-17 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 9,000 | $923.0K | +5.6% | open → |
| 2026-08-20 | 2026-08-17 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 2,100 | $213.7K | +6.4% | open → |
| 2026-08-20 | 2026-08-17 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 500 | $50.2K | +7.8% | open → |
| 2026-08-20 | 2026-08-17 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 900 | $89.1K | +9.5% | open → |
| 2026-08-20 | 2026-08-17 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $368.2K | +488.3% | open → |
| 2026-07-09 | 2026-07-08 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 1,035 | $83.0K | +35.1% | open → |
| 2026-07-09 | 2026-07-08 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 888 | $70.4K | +36.6% | open → |
| 2026-07-09 | 2026-07-08 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 1,923 | $23.2K | +797.3% | open → |
| 2026-06-04 | 2026-06-03 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 6,100 | $425.1K | +55.4% | open → |
| 2026-06-04 | 2026-06-03 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 2,000 | $137.5K | +57.6% | open → |
| 2026-06-04 | 2026-06-03 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 1,500 | $101.5K | +60.0% | open → |
| 2026-06-04 | 2026-06-03 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 400 | $26.5K | +63.2% | open → |
| 2026-06-04 | 2026-06-03 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 10,000 | $120.7K | +797.3% | open → |
| 2026-06-04 | 2026-06-02 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 3,400 | $226.9K | +62.3% | open → |
| 2026-06-04 | 2026-06-02 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 16,600 | $1.10M | +63.3% | open → |
| 2026-06-04 | 2026-06-02 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $241.4K | +797.3% | open → |
| 2026-06-04 | 2026-06-01 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 5,401 | $369.1K | +58.5% | open → |
| 2026-06-04 | 2026-06-01 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 12,989 | $875.6K | +60.7% | open → |
| 2026-06-04 | 2026-06-01 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 1,610 | $106.9K | +63.1% | open → |
| 2026-06-04 | 2026-06-01 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $241.4K | +797.3% | open → |
| 2026-05-13 | 2026-05-13 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 600 | $42.5K | +53.0% | open → |
| 2026-05-13 | 2026-05-13 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 3,950 | $275.7K | +55.2% | open → |
| 2026-05-13 | 2026-05-13 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 3,350 | $230.7K | +57.2% | open → |
| 2026-05-13 | 2026-05-13 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 2,100 | $143.0K | +59.0% | open → |
| 2026-05-13 | 2026-05-13 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 10,000 | $120.7K | +797.3% | open → |
| 2026-05-13 | 2026-05-12 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 2,800 | $204.7K | +48.1% | open → |
| 2026-05-13 | 2026-05-12 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 5,900 | $425.7K | +50.1% | open → |
| 2026-05-13 | 2026-05-12 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 9,802 | $699.6K | +51.8% | open → |
| 2026-05-13 | 2026-05-12 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 1,398 | $98.3K | +54.1% | open → |
| 2026-05-13 | 2026-05-12 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 100 | $6.8K | +59.6% | open → |
| 2026-05-13 | 2026-05-12 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $241.4K | +797.3% | open → |
| 2026-05-13 | 2026-05-11 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 6,700 | $444.4K | +63.3% | open → |
| 2026-05-13 | 2026-05-11 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 3,575 | $234.0K | +65.5% | open → |
| 2026-05-13 | 2026-05-11 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 9,725 | $628.5K | +67.6% | open → |
| 2026-05-13 | 2026-05-11 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $241.4K | +797.3% | open → |
| 2025-02-18 | 2025-02-16 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Tax | 38,668 | $2.25M | +85.8% | open → |
| 2025-02-18 | 2025-02-16 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 71,810 | $0.00 | — | open → |
| 2025-02-18 | 2025-02-15 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Tax | 7,098 | $413.7K | +85.8% | open → |
| 2025-02-18 | 2025-02-15 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 13,092 | $0.00 | — | open → |
| 2025-02-18 | 2025-02-16 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Tax | 9,087 | $529.7K | +85.8% | open → |
| 2025-02-18 | 2025-02-16 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 16,875 | $0.00 | — | open → |
| 2025-02-18 | 2025-02-16 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Tax | 11,313 | $659.4K | +85.8% | open → |
| 2025-02-18 | 2025-02-16 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 21,009 | $0.00 | — | open → |
| 2025-02-24 | 2025-02-23 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 22,436 | $0.00 | — | open → |
| 2025-02-24 | 2025-02-23 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Tax | 12,081 | $697.7K | +87.5% | open → |
| 2025-06-24 | 2025-06-23 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 20,000 | $1.05M | +106.0% | open → |
| 2025-06-24 | 2025-06-24 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 4,489 | $238.4K | +103.9% | open → |
| 2025-06-24 | 2025-06-24 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $162.2K | +1235.5% | open → |
| 2025-06-24 | 2025-06-24 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 15,511 | $836.2K | +100.9% | open → |
| 2025-06-24 | 2025-06-23 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $162.2K | +1235.5% | open → |
| 2025-06-24 | 2025-06-20 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 20,000 | $1.06M | +104.5% | open → |
| 2025-06-24 | 2025-06-20 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $162.2K | +1235.5% | open → |
| 2026-02-24 | 2026-02-23 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Tax | 12,104 | $855.0K | +53.3% | open → |
| 2026-02-24 | 2026-02-23 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 22,436 | $0.00 | — | open → |
| 2026-02-24 | 2026-02-20 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Tax | 9,040 | $641.7K | +52.6% | open → |
| 2026-02-24 | 2026-02-20 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 16,757 | $0.00 | — | open → |
| 2025-10-03 | 2025-10-03 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 724 | $51.9K | +51.1% | open → |
| 2025-10-03 | 2025-10-03 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 2,707 | $191.1K | +53.5% | open → |
| 2025-10-03 | 2025-10-03 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 2,334 | $163.0K | +55.1% | open → |
| 2025-10-03 | 2025-10-03 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 14,235 | $974.7K | +58.2% | open → |
| 2025-10-03 | 2025-10-03 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Exer. | 20,000 | $162.2K | +1235.5% | open → |
| 2025-10-03 | 2025-10-02 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 100 | $7.5K | +45.1% | open → |
| 2025-10-03 | 2025-10-02 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 700 | $51.3K | +47.9% | open → |
| 2025-10-03 | 2025-10-02 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 2,400 | $173.0K | +50.3% | open → |
| 2025-10-03 | 2025-10-02 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 10,200 | $727.0K | +52.0% | open → |
| 2025-10-03 | 2025-10-02 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 6,600 | $465.4K | +53.6% | open → |
| 2025-10-03 | 2025-10-02 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Exer. | 20,000 | $162.2K | +1235.5% | open → |
| 2025-10-03 | 2025-10-01 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 8,295 | $627.9K | +43.1% | open → |
| 2025-10-03 | 2025-10-01 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 11,705 | $879.2K | +44.2% | open → |
| 2025-10-03 | 2025-10-01 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Exer. | 20,000 | $162.2K | +1235.5% | open → |
| 2025-12-01 | 2025-12-01 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 261 | $18.7K | +51.3% | open → |
| 2025-12-01 | 2025-12-01 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 500 | $35.2K | +53.9% | open → |
| 2025-12-01 | 2025-12-01 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 5,402 | $375.1K | +56.0% | open → |
| 2025-12-01 | 2025-12-01 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 10,406 | $712.9K | +58.1% | open → |
| 2025-12-01 | 2025-12-01 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 16,569 | $134.4K | +1235.5% | open → |
| 2025-12-01 | 2025-11-26 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Gift | 25,000 | $0.00 | — | open → |
| 2025-11-12 | 2025-11-12 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 498 | $35.7K | +51.1% | open → |
| 2025-11-12 | 2025-11-12 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 6,784 | $482.3K | +52.4% | open → |
| 2025-11-12 | 2025-11-12 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 12,718 | $893.0K | +54.2% | open → |
| 2025-11-12 | 2025-11-12 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $162.2K | +1235.5% | open → |
| 2025-11-12 | 2025-11-11 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 11,500 | $801.9K | +55.3% | open → |
| 2025-11-12 | 2025-11-11 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 4,000 | $275.2K | +57.4% | open → |
| 2025-11-12 | 2025-11-11 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 4,500 | $305.5K | +59.5% | open → |
| 2025-11-12 | 2025-11-11 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $162.2K | +1235.5% | open → |
| 2025-11-12 | 2025-11-10 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 100 | $6.9K | +56.3% | open → |
| 2025-11-12 | 2025-11-10 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 19,900 | $1.37M | +57.6% | open → |
| 2025-11-12 | 2025-11-10 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $162.2K | +1235.5% | open → |
| 2025-07-10 | 2025-07-09 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $162.2K | +1235.5% | open → |
| 2025-07-10 | 2025-07-09 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 19,792 | $1.12M | +91.9% | open → |
| 2025-07-10 | 2025-07-08 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 3,598 | $196.0K | +98.8% | open → |
| 2025-07-10 | 2025-07-08 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 16,402 | $914.2K | +94.3% | open → |
